Moreover, this review emphasizes critical elements that are lacking in translation to unlock the full potential of GLP-1 RAs in the field of geroscience
We can go over your goals, expectations, and medical history to find a treatment plan that meets your specific needs
A central tenet of cGMP is that quality assurance is built into the drug product development life-cycle: from receipt of raw materials to patient administration
In the SWITCH-2 study, participants who switched to tirzepatide 5 mg from GLP-1 RAs experienced an additional HbA1c reduction at week 12 with tirzepatide (0.43%) versus semaglutide (0.36%), also aligned with the results from the current analyses [33]
Semaglutide activates GLP-1 (glucagon-like peptide-1) receptors distributed throughout the GI tract, significantly slowing gastric emptying and small intestine transit time
Diabetologia 56 (5), 973984